|
New York, NY, November 11, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for Dyax (NASDAQ:DYAX) for its twelve months ended September 30, 2009 increased by 55.2% to $46,770,000. This com ... read full story |
|
| Website Address: |
www.dyax.com |
| Industry: |
Bio-Pharma & Therapeutics
|
|